23 Feb Avectas Limited

Posted at 18:44h in by brady

Michael Maguire, CEO

April 11 | 10:30am | Salone dei Cavalieri, Section 2

Dublin, Ireland

(Private)

Avectas has developed Solupore, a ground-breaking non-viral cell engineering platform for next-gen cell therapies. It excels at yielding cells with high viability, functionality, and potent cytotoxicity for patient dosing, after complex gene editing. Solupore gives therapeutic developers new manufacturing options including

www.avectas.com

About the Event

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

Dates & Location

April 9-11, 2024
Rome Cavalieri
Via Alberto Cadlolo 101
Rome, Italy

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions